HIV trials in France

In France 50 Also abroad 795

21 of 50 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Active, not recruiting
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Where
Bordeaux Cedex, Caen, Nantes, Nimes Cedex 9, Paris, Paris Cedex 18
Age
18 years and over
People
186 worldwide
Run by
ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00
Phase 2/3Taking people
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Where
Bobigny Cedex, Bordeaux, Creteil, Lyon Cedex 04, Montpellier Cedex 5, Nantes, Nice, Nîmes, Paris, Paris Cedex 18, Toulouse, Tourcoing Cedex
Age
18 years and over
People
570 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07266831 · EU 2025-522519-40-00
No phaseTaking people
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
Where
Nice
Age
75 years and over
People
136
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07388394
Phase 2Not yet taking people in France
Immunotherapy with a JAK1/JAK2 inhibitor (baricitinib) and an mTORC1 inhibitor (sirolimus), alone and in combination, for the control of HIV-1 replication after antiretroviral treatment interruption: a phase II multicenter, multi-arm, multi-stage, randomized, double-blind, placebo-controlled, adaptative trial
Where
Aix En Provence, Bobigny Cedex, Bordeaux, Creteil, Dijon, Garches, Le Kremlin-Bicetre, Lyon Cedex 04, Marseille, Montpellier Cedex 5, Nantes, Nimes Cedex 9, Orleans Cedex 2, Paris, Paris Cedex 10, Paris Cedex 13, Paris Cedex 18, Perpignan Cedex, Rennes, Suresnes, Toulouse, Tourcoing Cedex, Tours
Age
18 years to 64 years
People
195
Run by
ANRS Maladies Infectieuses Emergentes
See details and how to joinNCT07081763 · EU 2025-523118-97-00
Phase 2Taking people
Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 antiviral treatment relief strategies, in patients co-infected with the HIV-1 and HBV viruses
Where
Bobigny Cedex, Bondy, Bordeaux, Créteil, Dijon, Garches, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Paris Cedex 12, Paris Cedex 13, Paris Cedex 20, St Denis, Toulouse, Tourcoing Cedex
Age
18 years to 64 years
People
140
Run by
Inserm
See details and how to join2023-508634-34-00
Phase 3Taking people
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Where
Bordeaux, Lyon Cedex 04, Nantes, Paris, Toulouse
Age
18 years and over
People
183 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2025-524336-19-00
Phase 3Taking people
ANRS0392s ELDORADO : Phase III, open-label, randomized, multicenter trial EvaLuating the non-inferiority of DORAvirine versus DOlutegravir based antiretroviral regimens in treatment-naïve people living with HIV-1 infection
Where
Bordeaux, Montpellier, Nantes, Paris, Paris Cedex 12
Age
18 years and over
People
60
Run by
Inserm
See details and how to joinNCT06203132 · EU 2023-508626-10-00
Phase 3Taking people
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
Where
Paris
Age
18 years and over
People
524 worldwide
Run by
ANRS, Emerging Infectious Diseases
See details and how to joinNCT05813964 · EU 2022-502931-20-00
No phaseNot yet taking people in France
Strengthening, Guidance, Health, Empowerment
Where
Montpellier
Age
18 years and over
People
200
Run by
University Hospital, Montpellier
See details and how to joinNCT07788599
Phase 3Completed
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
Where
Lyon Cedex 04, Montpellier Cedex 5, Nantes, Paris, Paris Cedex 18, Tourcoing Cedex
Age
18 years and over
People
120 worldwide
Run by
Gilead Sciences Inc.
See details and how to joinNCT06333808 · EU 2023-510022-33-00
Phase 3Withdrawn
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Where
Le Kremlin-Bicetre, Nantes, Nice, Paris, Paris Cedex 18, Strasbourg Cedex
Age
18 years and over
People
183 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2025-524335-39-00
Phase 3Taking people
MODULO
Where
Angers, Argenteuil Cedex, Bobigny, Bordeaux, Bordeaux Cedex, Boulogne-Billancourt, Clamart, Clermont-Ferrand Cedex 1, Dijon, Fort De France Cedex, Garches, La Roche Sur Yon Cedex 9, Limoges, Marseille, Montpellier Cedex 5, Nantes, Nice, Orleans Cedex 2, Paris, Paris Cedex 12, Paris Cedex 13, Paris Cedex 20, Pointe-à-Pitre Cedex, Quimper Cedex, Reims Cedex, Rennes, Saint-Priest-en-Jarez, St Denis Cedex, Strasbourg, Toulouse, Tourcoing Cedex, Villeneuve-Saint-Georges
Age
18 years and over
People
408
Run by
Centre De Recherches Et D'Etudes Sur La Pathologie Tropicale Et Le Sida
See details and how to joinNCT06774872 · EU 2024-515793-27-01
No phaseTaking people
the ANRS CO21 " Extreme " Cohort (CODEX)
Where
Le Kremlin-Bicêtre
Age
18 years to 85 years
People
450
Run by
ANRS, Emerging Infectious Diseases
See details and how to joinNCT01520844
No phaseTaking people
#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
Where
Marseille
Age
18 years and over
People
5,200 worldwide
Run by
Casper Rokx
See details and how to joinNCT06900829
No phaseTaking people
Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study
Where
Saint-Paul, Saint-Pierre
Age
30 years to 65 years
People
300
Run by
Centre Hospitalier Universitaire de la Réunion
See details and how to joinNCT07438080
No phaseTaking people
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Where
Avranches, Barentin, Dieppe, Elbeuf, Gisors, Le Havre, Pont-Audemer, Rouen, Yvetot
Age
18 years and over
People
500
Run by
University Hospital, Rouen
See details and how to joinNCT05390424
No phaseTaking people
Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset
Where
La Roche-sur-Yon, Le Coudray, Nantes, Orléans, Poitiers
Age
18 years and over
People
120
Run by
Centre Hospitalier Régional d'Orléans
See details and how to joinNCT06834113
Phase 2Taking people
DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Where
Caen Cedex 9, Montpellier Cedex 5, ORLEANS, Paris, Paris Cedex 10, Rouen Cedex, Tourcoing Cedex
Age
18 years and over
People
32
Run by
University Hospital, Caen
See details and how to joinNCT06034938 · EU 2023-505845-17-00
Phase 2Not yet taking people in France
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Where
Paris Cedex 13
Age
18 years and over
People
150 worldwide
Run by
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
See details and how to joinNCT04513626 · EU 2024-513941-35-00
Phase 2Taking people
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Where
Bobigny, Clamart, Clichy, Créteil, Garches, Le Kremlin-Bicêtre, Paris, Suresnes, Villeneuve-Saint-Georges
Age
18 years to 70 years
People
69
Run by
ANRS, Emerging Infectious Diseases
See details and how to joinNCT05300035
Phase 2/3Taking people
Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection
Where
Clermont-Ferrand, Nantes, Paris, Paris Cedex 13, Toulouse
Age
18 years and over
People
33
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06276504 · EU 2023-503520-31-00